Founded in 2013, Koye Pharmaceuticals operates in Health Tech offering specialised pharmaceutical products and services within the Indian market. The company has a significant presence across the coun...
Funding stage:
Debt Financing
Last funding:
01/09/2020
Total funding:
$4.10 Mn+
Revenue:
Investors
Employee count:
731
Last 90d
731
Last 90d
Web traffic:
1.67K
1.67K
Last 30d
Last 30d
Glassdoor Rating:
Koye Pharmaceuticals: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders6
Latest Filing Date30 July 2025- Funding Events22
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Koye Pharmaceuticals
As of 31 July 2025, Koye Pharmaceuticals's equity is held by 6 shareholders, with the top three being Koye, Sequoia Capital India Investment IV, and SCI Growth Investment II.
Koye holds the largest stake in Koye Pharmaceuticals at 27.6% as of 31 July 2025.
As of 31 July 2025, investors collectively hold 72.4% equity in Koye Pharmaceuticals.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links